1. Home
  2. ENOV vs PSEC Comparison

ENOV vs PSEC Comparison

Compare ENOV & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • PSEC
  • Stock Information
  • Founded
  • ENOV 1995
  • PSEC 2004
  • Country
  • ENOV United States
  • PSEC United States
  • Employees
  • ENOV N/A
  • PSEC N/A
  • Industry
  • ENOV Fluid Controls
  • PSEC Finance/Investors Services
  • Sector
  • ENOV Industrials
  • PSEC Finance
  • Exchange
  • ENOV Nasdaq
  • PSEC Nasdaq
  • Market Cap
  • ENOV 2.1B
  • PSEC 1.9B
  • IPO Year
  • ENOV 2008
  • PSEC 2004
  • Fundamental
  • Price
  • ENOV $36.95
  • PSEC $4.04
  • Analyst Decision
  • ENOV Buy
  • PSEC Sell
  • Analyst Count
  • ENOV 4
  • PSEC 1
  • Target Price
  • ENOV $58.50
  • PSEC $4.50
  • AVG Volume (30 Days)
  • ENOV 849.1K
  • PSEC 2.7M
  • Earning Date
  • ENOV 05-01-2025
  • PSEC 05-07-2025
  • Dividend Yield
  • ENOV N/A
  • PSEC 15.59%
  • EPS Growth
  • ENOV N/A
  • PSEC N/A
  • EPS
  • ENOV N/A
  • PSEC N/A
  • Revenue
  • ENOV $2,107,623,000.00
  • PSEC $796,249,000.00
  • Revenue This Year
  • ENOV $7.09
  • PSEC N/A
  • Revenue Next Year
  • ENOV $6.38
  • PSEC N/A
  • P/E Ratio
  • ENOV N/A
  • PSEC N/A
  • Revenue Growth
  • ENOV 23.45
  • PSEC N/A
  • 52 Week Low
  • ENOV $34.44
  • PSEC $4.00
  • 52 Week High
  • ENOV $62.79
  • PSEC $5.72
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 38.61
  • PSEC 28.08
  • Support Level
  • ENOV $36.43
  • PSEC $4.00
  • Resistance Level
  • ENOV $38.56
  • PSEC $4.28
  • Average True Range (ATR)
  • ENOV 1.44
  • PSEC 0.07
  • MACD
  • ENOV 0.08
  • PSEC -0.02
  • Stochastic Oscillator
  • ENOV 40.10
  • PSEC 12.12

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Share on Social Networks: